{"id":"W4409144909","doi":"10.1016/j.ejcskn.2025.100586","title":"A Phase 3 trial of fixed-dose combination of fianlimab + cemiplimab vs relatlimab + nivolumab in patients with unresectable or metastatic melanoma","year":2025,"lang":"en","type":"article","venue":"EJC Skin Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Nivolumab; Medicine; Oncology; Melanoma; Internal medicine; Phase (matter); Metastatic melanoma; Radiology; Cancer research; Immunotherapy; Cancer; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001817514,0.002079431,0.003125977,0.0005622323,0.0005713647,0.001692312,0.00138508,0.001711058,0.007213663],"category_scores_gemma":[0.00132812,0.0007956112,0.002996425,0.000457948,0.001349048,0.001842402,0.0004636589,0.006414501,0.001683465],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001419864,"about_ca_system_score_gemma":0.001539903,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00167024,"about_ca_topic_score_gemma":0.003908379,"domain_scores_codex":[0.9994175,0.0002395866,0.00002082546,0.0001328815,0.00003559402,0.000153498],"domain_scores_gemma":[0.9992398,0.0001749924,0.0001022595,0.00006670848,0.00003710252,0.0003792062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9371251,0.01841007,0.0008304625,0.0003859992,0.00114412,0.00006188656,0.0001023553,0.001503336,0.00462081,0.000199174,0.00212639,0.03349018],"study_design_scores_gemma":[0.8141434,0.1800017,0.002517993,0.00002871627,0.000425457,0.00006509563,0.00004510255,0.0009961992,0.0004972903,0.0002908355,0.0009599189,0.00002815083],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862705,0.004086663,0.0007096691,0.001313995,0.0009574966,0.001973443,0.001184246,0.0001861807,0.003317944],"genre_scores_gemma":[0.9880824,0.001620478,0.001579273,0.001479384,0.0003852865,0.001709862,0.001593256,0.00005455532,0.003495532],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007213663,"threshold_uncertainty_score":0.02413207,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01461065501911946,"score_gpt":0.3161808704942925,"score_spread":0.301570215475173,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}